This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

  • Products
  • Therapy Areas
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
HF-Impact Banner

Navigating ATTR-CM Diagnosis: Explore Our Resources

Learn more about the diagnoses of ATTR-CM from experts in the field in these short videos, covering topics on:

Developments in ATTR-CM Diagnosis - What are the red flags to look out for - How to differentiate between ATTR-CM and cardiomyopathy - Understanding ATTR-CM from a patients perspective - Advice for counseling patients with ATTR-CM

  • Prof. Rick Steeds - Consultant Cardiologist at University Hospitals (Queen Elizabeth) Birmingham
  • Ms. Christine Chiti - Clinical TTR Nurse specialist at the National Amyloidosis Centre Royal Free Hospital in London
  • Dr. Jason Dungu - Consultant Cardiologist at Essex Cardiothoracic Centre

Prof. Rick Steeds discusses the Evolution of ATTR-CM diagnosis and what the future looks like.

Ms. Christine Chiti discusses ATTR-CM from a patients perspective including, how patients feel, advice for HCP's managing patients and what symptoms to look out for.

Dr. Jason Dungu discusses the Identification and Diagnosis of ATTR-CM; What are the symptoms and red flags, diagnostic testing and assessment and how to differentiate between ATTR-CM and Cardiomyopathy.

Prescribing information for BEYONTTRA® (acoramidis) can be found here.

Upcoming Events:

Register for BayerPRO - Beyonttra

Register for BayerPRO

Stay up to date on future events and webinars posted by registering to BayerPRO here.

Register Now

Prescribing information for BEYONTTRA®▼(acoramidis) can be found here.

 

Abbreviation:

ATTR-CM, Transthyretin Amyloid Cardiomyopathy.

 

PP-PF-CAR-GB-0060 | October 2025